Lactiplantibacillus plantarum 299V clinical trials
Also written Lactobacillus plantarum 299v, Lp 299v and DSM 9843.
Counted the way a researcher would: Lactiplantibacillus plantarum 299V with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses lactiplantibacillus plantarum 299V is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lactiplantibacillus plantarum 299V studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 7
Children's Oncology Group (1) · Medical University of Gdansk (1) · Medical University of Bialystok (1) · University of Stellenbosch (1) · University of Illinois Chicago (1) · Massachusetts Eye and Ear Infirmary (1) · Stanford University (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test lactiplantibacillus plantarum 299V.
- Jun 2027Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular EdemaPhase 2 · Massachusetts Eye and Ear Infirmary
Studies
Open first, then newest update. How each study uses lactiplantibacillus plantarum 299V is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant FemalesRecruitingPhase 2University of Illinois ChicagoNCT07076849Written as Lactiplantibacillus plantarum 299vHow we know
- Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular EdemaRecruitingPhase 2Massachusetts Eye and Ear InfirmaryNCT07383701Written as Lactobacillus plantarum 299vHow we know
- Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell TransplantActive, not recruitingPhase 3Children's Oncology GroupNCT03057054Written as Lactobacillus plantarum strain 299vHow we know
- The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral NutritionCompletedNot applicableMedical University of GdanskNCT03940768Written as Lactobacillus plantarum 299vHow we know
- Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression TreatmentCompletedPhase 2Medical University of BialystokNCT02469545Written as Lactobacillus Plantarum 299vHow we know
- Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel SyndromeCompletedPhase 4University of StellenboschNCT01886781Written as Lactobacillus plantarum 299vHow we know
- Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing ChemotherapyWithdrawnPhase 2Stanford UniversityNCT01644097Written as Lactobacillus plantarum strain 299vHow we know
Codes
What other systems call lactiplantibacillus plantarum 299V · ClinicalTrials.gg INT017585
- UNII (FDA) PH2Q4E64WMLACTIPLANTIBACILLUS PLANTARUM 299VOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PH2Q4E64WM | LACTIPLANTIBACILLUS PLANTARUM 299V | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.